Presentation is loading. Please wait.

Presentation is loading. Please wait.

Prediction of the effects of gonadotropin-releasing hormone agonist therapy in uterine leiomyoma by T1 contrast-enhanced magnetic resonance imaging sequences 

Similar presentations


Presentation on theme: "Prediction of the effects of gonadotropin-releasing hormone agonist therapy in uterine leiomyoma by T1 contrast-enhanced magnetic resonance imaging sequences "— Presentation transcript:

1 Prediction of the effects of gonadotropin-releasing hormone agonist therapy in uterine leiomyoma by T1 contrast-enhanced magnetic resonance imaging sequences  Masahiro Kadowaki, M.D., Takashi Murakami, M.D., Ph.D., Junko Morita, M.D., Yukihiro Terada, M.D., Ph.D., Nobuo Yaegashi, M.D., Ph.D., Kunihiro Okamura, M.D., Ph.D.  Fertility and Sterility  Volume 77, Issue 5, Pages (May 2002) DOI: /S (02)

2 FIGURE 1 Correlation between enhancement and reduction rates. The Spearman correlation coefficient and corresponding P value were .94 and <.001, respectively. The horizontal line represents a reduction rate of 0%. Myomas that became larger after GnRH agonist therapy appear below this line. Kadowaki. GnRH agonist effect in myoma. Fertil Steril 2002. Fertility and Sterility  , DOI: ( /S (02) )


Download ppt "Prediction of the effects of gonadotropin-releasing hormone agonist therapy in uterine leiomyoma by T1 contrast-enhanced magnetic resonance imaging sequences "

Similar presentations


Ads by Google